cvot tirzepatide SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Post hoc analysis of SURPASS-CVOT

When cost is excluded as a factor, the leading reason for discontinuation is gastrointestinal side effects, most notably nausea and vomiting, as reported by patients (Sikirica et al., 2017)

At the receptor level, cagrilintide activates amylin receptors, which are heterodimers consisting of the calcitonin receptor (CTR) combined with receptor activity-modifying proteins (RAMPs)

Mounjaro (Tirzepatide) is a medication that helps regulate blood sugar and promote weight loss

This is more commonly observed after starting insulin therapy but can occasionally occur with other glucose-lowering medications that achieve significant HbA1c reductions